Señales en vivo de 048410.KQ | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 abr 2024 @ 02:30):

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body...

Stats
Volumen de hoy	211 771
Volumen promedio	470 669
Capitalización de mercado	808.31B
EPS	KRW0 ( 2024-02-25 )
Próxima fecha de ganancias	( KRW0 ) 2024-05-13
Last Dividend	KRW0 ( N/A )
Next Dividend	KRW0 ( N/A )
P/E	0
ATR14	KRW50.50 (0.25%)

Volumen Correlación

Largo: -0.11 (neutral)

Corto: -0.17 (neutral)

Signal:(53.603) Neutral

Hyundai Bioscience Co., Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Hyundai Bioscience Co., Correlación - Moneda/Commodity

-0.15
( neutral )

-0.16
( neutral )

0.06
( neutral )

-0.01
( neutral )

-0.52
( weak negative )

0.06
( neutral )

Hyundai Bioscience Co., Finanzas

Annual	2023
Ingresos:	KRW9.48B
Beneficio Bruto:	KRW3.92B (41.36 %)
EPS:	KRW-364.53

FY	2023
Ingresos:	KRW9.48B
Beneficio Bruto:	KRW3.92B (41.36 %)
EPS:	KRW-364.53

FY	2022
Ingresos:	KRW7.85B
Beneficio Bruto:	KRW1.95B (24.79 %)
EPS:	KRW-401.53

Financial Reports:

No articles found.

Hyundai Bioscience Co.,

Hyundai Bioscience Co., Ltd., a biotechnology company, develops and commercializes bio-fusion technology for delivering active ingredients to human body. The company provides Vitabrid C12, a new-conceptual vitamin C product that delivers active vitamin C into the skin. It also develops organic-inorganic hybrid technology, a drug delivery system technology that allows the selective and effective delivery of active substances on the target area in combination with bio-friendly minerals, as well as in anticancer drug carrier technology. The company was founded in 2000 and is based in Seoul, South Korea.